Oxidative stress involvement in schizophrenia pathophysiology: A review;Implication du stress oxydant dans la physiopathologie de la schizophrénie: Revue de la littérature

Encephale

Volumn 32, Issue 2, 2006, Pages 244-252

  Fendri, C ^a   Mechri, A ^a   Khiari, G ^a   Othman, A ^b   Kerkeni, A ^b   Gaha, L ^a  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Antioxidant defence; Antioxidant treatment; Free radicals; Oxidative stress; Schizophrenia

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; AMISULPRIDE; ASCORBIC ACID; BILIRUBIN; CARBAMAZEPINE; CATALASE; CHLORPROMAZINE; FLUPENTIXOL; FREE RADICAL; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HALOPERIDOL; NEUROTRANSMITTER; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PLASMA PROTEIN; PROMETHAZINE; RETINOL; SUPEROXIDE DISMUTASE; TRACE ELEMENT; URIC ACID;

ANTIOXIDANT ACTIVITY; BIOCHEMISTRY; BRAIN CELL; BRAIN TISSUE; CELL MEMBRANE; CORRELATION ANALYSIS; DYNAMICS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; MEMBRANE DAMAGE; MEMBRANE FLUIDITY; MEMBRANE PERMEABILITY; MEMBRANE STRUCTURE; METABOLISM; NEUROTRANSMISSION; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHOLIPID METABOLISM; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY; TOXICITY;

EID: 33646377916     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0013-7006(06)76151-6     Document Type: Article

References (48)

1. ABDALLA DSP, MANTEIRO HP, OLIVERA JAC et al. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic depressive patients. Clin Chem 1986 ; 32 : 805-7.
2. AKYOL O, HERKEN H, UZ E et al. The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. Progr Neuropsychopharmacol Biol Psychiatry 2002 ; 26 : 995-1005.
3. ALTUNTAS I, AKSOY H, COSKUN I et al. Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients. Clin Chem Lab Med 2000 ; 38 (12) : 1277-81.
4. ARNOLD SE, HYMAN BT, VAN HOESEN GW et al. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991 ; 48 : 625-32.
5. AVERNACK P. Structural lesions of the brain of young schizophrenics. Can J Neurol Sci 1981 ; 8 : 73-6.
6. BUCKMAN TD, KLING AS, EIDUSON S et al. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities : relation to psychosocial variables. Psychiatr Res 1990 ; 31 : 1-14.
7. CHEN YLR, CHEN YHE, MAK FL. Soft neurological signs in schizophrenic patients and their non psychotic siblings. J Nerv Ment Dis 2000 ; 188 : 84-9.
8. CROW TJ. Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 1980 ; 137 : 383-6.
9. DUSICA P, TAMBURI V, STOJJANOVI I et al. Oxidative stress as marker of positive symptoms. Med Biol 2002 ; 9 : 157-61.
10. EVANS PH. Free radicals in brain metabolism and pathology. Br Med Bull 1993 ; 49 : 577-87.
11. FAVIER A. Le stress oxydant : intérêt de sa mise en évidence en biologie médicale et problèmes posés par le choix d'un marqueur. Ann Biol Clin 1997 ; 55 (1) : 9-16.
12. FULBERT JC, CALS MJ. Les radicaux libres en biologie clinique : origine, rôle pathogène et moyen de défense. Path Biol 1992 ; 40 (1) : 66-77.
13. GLOSE B, DEBRAY Q, PUGET K et al. Superoxide dismutase and glutathione peroxidase levels in erythrocytes of adult schizophrenics. N Press Med 1978 ; 7 (23) : 2070-1.
14. GREEN MF, SATZ P, CHRISTENSON C. Minor physical anomalies in schizophrenia patients, bipolar patients, and their siblings. Schizophr Bull 1994; 20 : 433-40.
15. HALLIWELL B. Cigarette smoking and health : a radical view. J Soc Health 1993 ; 113 : 91-6.
16. HARRISON PJ. The neuropathy of schizophrenia. A critical review of the data and their interpretation. Brain 1999 ; 122 : 593-624.
17. HERKEN H, UZ E, OZYURT H et al. Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol Psychiatr 2001 ; 6 (1) : 66-73.
18. HERKEN H, UZ E, ZYURTÖ et al. Red blood cell nitric oxide levels in patients with schizophrenia. Schizophr Res 2001 ; 52 : 289-90.
19. HIRAMASTSU M, KOHNO M, EDAMATSU R et al. Increased superoxide dismutase activity in aged human cerebrospinal fluid. J Neurochem 1992 ; 58 : 114-6.
20. HORROBIN DF. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 1998 ; 30 : 193-208.
21. ISMAIL B, CANTOR-GRAAE E, McNEIL TF. Minor physical anomalies in schizophrenic patients and their siblings. Am J Psychiatry 1998 ; 155 : 1695-702.
22. ISMAIL B, CANTOR-GRAAE E, McNEIL TF. Neurological abnormalities in schizophrenic patients and their siblings. Am J Psychiatry 1998 ; 155 : 84-9.
23. JABLENSKY A. Epidemiological surveys of mental health of geographically defined populations in Europe. In: Weissman M, Meyers J, Ross C, eds. Community surveys of psychiatric disorders. New Brunswick, NJ : Rutgers University Press, 1986 : 257-313.
24. JORG B, SCHULZ, JORG L et al. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000 ; 267 : 4904-11.
25. KHAN NS, DAS I. Oxidative stress and superoxide dismutase in schizophrenia. Biochem Soc Trans 1997 ; 25 (3) : 418S.
26. LOHR JB, FLYNN K. Smoking and schizophrenia. Schizophr Res 1992 ; 8 : 93-102.
27. LOHR JB. Oxygen radicals and neuropsychiatric illness. Arch Gen Psychiatry 1991 ; 48 : 1097-106.
28. LOHR JB, KUCZENSKI R, BRACHA HS et al. Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol Psychiatry 1990 ; 28 : 535-9.
29. MAHADIK SP, MUKHERJEE S, SCHEFFER R et al. Elevated plasma lipid peroxides at the onset of nonaffective psychosis. Biol Psychiatry 1998 ; 43 : 674-9.
30. MAHADIK SP, MUKHERJEE S. Free radical pathology and antioxidant defense in schizophrenia : a review. Schizophr Res 1996 ; 19 : 1-17.
31. McCREADIE RG, McDONALD E, WILES D et al. Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and normal subjects. Br J Psychiatry 1995 ; 167 : 610-17.
32. MUKHERJEE S, MAHADIK SP, SCHEFFER R et al. Impaired antioxidant defense at the onset of psychosis. Schizophr Res 1996 ; 19 : 19-26.
33. MUKHERJEE S, MAHADIK SP, CORRENTI EE. The antioxidant defense system at the onset of psychosis. Biol Psychiatry 1994 ; 35 : 701.
34. NGUIMFACK MBODIE PC. La théorie de l'excitotoxicité du glutamate et l'implication potentielle des radicaux libres dans l'étiopathogénie de la schizophrénie. Encephale 2002 ; 27 : 147-53.
35. OLNEY JW, FARBER NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995 ; 52 : 998-1007.
36. 31P nuclear magnetic resonance spectroscopy : neuro-development and schizophrenia. Schizophr Bull 1993 ; 19 : 335-53.
37. REDDY D, YAO JK. Radical pathology in schizophrenia : a review. Prostagl Leukotr Essent Fatt Acids 1996 ; 55 (1-2) : 33-43.
38. SCHISLER NJ, SINGH SM. Effect of ethanol in vivo on enzymes which detoxify oxygen free radicals. Free Rad Biol Med 1989 ; 7 : 117-28.
39. SCOTTISH SCHIZOPHRENIA RESEARCH GROUP. Smoking habits and plasma lipid peroxide and vitamin E levels in never-treated first-episode patients with schizophrenia. Br J Psychiatry 2000 ; 176 : 290-3.
40. 2 : possible role of oxygen radicals. J Neurochem 1988 ; 50 : 565-71.
41. SUBOTICANEE K, FOLNEGOVIC-SAMALC V, KORBAR M et al. Vitamin C status in chronic schizophrenia. Biol Psychiatry 1990 ; 28 : 959-66.
42. VAILLE-PERRET E, MOTTA C, JALENQUES I. Étude de l'évolution clinique et des modifications de fluidité membranaire chez les patients schizophrènes traités par neuroleptiques. Ann Med Psychol 2002 ; 160 : 58-66.
43. VAIVA G, THOMAS P, LEROUX JM et al. Dosages de la superoxyde dismutase érythrocytaire (SODe) dans les moments productifs de psychose. Therapie 1994 ; 49 : 343-8.
44. YAO JK, REDDY RD, VAN KAMMEN DP. Oxidative damage and schizophrenia : an overview of the evidence and its therapeutic implications. CNS Drugs 2001 ; 15 (4) : 287-310.
45. YAO JK, REDDY R, VAN KAMMEN DP. Human plasmaglutathione peroxidase and symptom severity in schizophrenia. Biol Psychiatry 1999 ; 45 : 1512-5.
46. YAO JK, REDDY R, McELHINNY LG et al. Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophr Res 1998 ; 32 (1) : 1-8.
47. YAO JK, REDDY RD, McELHINNY LG et al. Effect of haloperidol on antioxidant defense system enzymes in schizophrenia. J Psychiatr Res 1998 ; 32 : 385-91.
48. YUVAL M, PINKHAS S, DROW DR et al. Superoxide anion production by neutrophils derived from peripheral blood of schizophrenic patients. Psychiatr Res 1998 ; 77 : 29-34.